United Therapeutics Corp.is working with Varda Space Industries Inc.to explore the use of microgravity in creating drugs for chronic diseases in a deal that could prove out the value of in-space development for the pharmaceutical industry.
Varda, backed by Peter Thiel’s Founders Fund, will send United Therapeutics’ medicines into orbit on small capsules with no crew, where the drug samples will undergo chemical processing in space, according to Michael Reilly, chief strategy officer at El Segundo, California-based Varda.
WATCH: Varda Space is planning to send medicines from United Therapeutics into orbit to explore the use of microgravity in creating drugs. Source: Bloomberg
United Therapeutics’ scientists then will study the effects of microgravity on the molecules days or ...